BioIntelliSense
CompanyUnited States
BioIntelliSense develops 2 assets, the furthest in human trials (BioButton in mobility impairments). Mostly device; based in the United States.
- 2
- Assets
- Furthest stage
- Human trials
- 0
- Trials
- 0
- Signals
Pipeline
2Torso-mounted wearable sensor that continuously monitors gait, step counts, and physical mobility.
Human trials, Device, mobility impairments
Continuous torso-mounted wearable sensor measuring gait and mobility in older adults to reduce fall risk.
Stage not known, Device
Full company profiles: pipeline, trials, funding and people.
Papers
Geriatric nursing (New York, N.Y.), 1 Sept 2026